Spherix Inc Share Price Nasdaq
Equities
US84842R2058
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2022 | - | Sales 2023 | 2.04M 159M | Capitalization | 15.37M 1.2B |
---|---|---|---|---|---|
Net income 2022 | -22M -1.72B | Net income 2023 | -22M -1.72B | EV / Sales 2022 | - |
Net cash position 2022 | 41.56M 3.24B | Net cash position 2023 | 12.93M 1.01B | EV / Sales 2023 | 1.2 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-0.59
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.45% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Hayes
CEO | Chief Executive Officer | 56 | 28/02/13 |
Kyle Wool
PSD | President | - | 11/04/21 |
George M. Way
DFI | Director of Finance/CFO | - | 02/04/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Ledwick
BRD | Director/Board Member | 66 | 08/07/15 |
Anthony Hayes
CEO | Chief Executive Officer | 56 | 28/02/13 |
Gregory Blattner
BRD | Director/Board Member | 47 | 02/05/18 |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |